- Lentinan is a polysaccharide from the shiitake mushroom (Lentinula edodes) — in Japan, an officially used oncology adjunct.
- It activates macrophages, T-cells and NK cells, and helps block the PD-L1/CD47/CD24 cloaking signals cancer cells use to evade immunity.
- Quality criteria: water-based extract, at least 30% polysaccharides, at least 1200 mg/day - cheap 5-15% powders are 2-6x weaker.
- A multi-extract formula paired with the antioxidant astaxanthin is studied as more effective than single ingredients.
Medicinal mushrooms
Mushrooms have always held an unusual place in the human psyche and in our evolution, long associated with power and mystery — used for food, ritual, and, of course, healing. Mushrooms are neither plants nor animals, which makes them especially attractive to scientists, because they contain a range of substances found nowhere else. It all began with the antibiotic penicillin (extracted from the Penicillium mushroom), estimated to have saved up to 200 million lives.1 The rapidly growing volume of research worldwide proves the value of mushrooms for treating and preventing health problems. Few people know that active compounds extracted from mushrooms are widely used in medicine: antibacterial agents,2 the statins used to lower cholesterol (also derived from a mushroom, patented in 1979),3 and antifungal drugs.
How cancer cells protect themselves from immunity
Normally, immune cells — macrophages — find and destroy altered cells. But cancer cells have various survival strategies. They use sophisticated proteins such as PD-L1, CD47 and CD24 which, once attached to the cell surface, send a "do not attack me" signal.7 Macrophages receiving this signal do not attack the altered cells, believing them to be healthy — a kind of cloak of invisibility for cancer cells. Blocking these signals is the basis of some anticancer therapies.8 Natural immunoregulators such as Lentinan are known to help block this cancer-cell signal,9 making it easier for immune cells to detect the altered cells.
Lentinan — a polysaccharide of Lentinula edodes

From a medical standpoint, Lentinula edodes (the shiitake mushroom) is a "heavyweight" mushroom that combats many health disorders. Used for thousands of years in Eastern medicine, it contains unique substances. One of them is the polysaccharide Lentinan, which has antibacterial, antimicrobial, antiviral, anticancer and immune-stimulating properties.
How does Lentinan work?
Lentinan binds to the surface of lymphocytes, which activates macrophages, T-helper cells and NK cells (natural killer cells). It increases the production of antibodies, including interleukins (IL-2) and interferon (IFN-γ). This triggers the attack on foreign bodies, bacteria, viruses or altered cells. The activity and interaction of these cells is what we call the immune system. Research also shows that the compounds of this remarkable mushroom are effective in protecting against the side effects of radiotherapy and chemotherapy.
Is taking Lentinan "alternative" (non-conventional) medicine?
In some countries, unfortunately, yes. But in some states — even highly developed ones like Japan — it has long ceased to be alternative medicine. In Japan, the active compounds extracted from Lentinula edodes are prescribed in cancer cases, used before, during and after chemo/radiotherapy, because they slow tumour growth and spread and reduce the likelihood of recurrence. In fact, in Japan, polysaccharide-based supplements are leading preparations prescribed in cancer treatment.
When is Lentinan used?
Because Lentinan stimulates and strengthens the immune system, this polysaccharide is used for a vast range of ailments. The person who contributed most to today's enormous interest in the active compounds of Lentinula edodes was the Japanese Ph.D. Dr. Kisaku Mori. As early as 1936 he founded the Mushroom Research Institute in Tokyo. Until his death, Dr. Mori worked with scientists from around the world, studying the medicinal properties of polysaccharides. Through years of research on the human body, he discovered that this active compound is effective for a very long list of diseases — showing antiviral, antibacterial and antitumour properties.
What else to take?
Antioxidants. A study of antioxidant use during and after chemotherapy, comparing 93 clinical trials,10 found that in 70% of cases chemotherapy effectiveness increased, in 88% of cases antioxidant use eased the toxicity caused by chemotherapy, and in 63% of cases patient survival time was extended. The strongest known natural antioxidant is astaxanthin. Make sure astaxanthin accompanies Lentinan — which is exactly why a formula combining several mushroom extracts with an antioxidant (astaxanthin) is more effective than single ingredients.
Lentinan helps block the cloaking signals cancer cells use to hide. A water-based, high-polysaccharide formula paired with astaxanthin is studied as more effective than single ingredients.
Lentinan AXT by Zenius Labs™ →Lentinan is a polysaccharide extracted from the medicinal mushroom Lentinula edodes (shiitake). It has immunomodulating, antiviral and antitumour properties. In Japan, Lentinan is officially used as an adjunct in the treatment of oncological diseases.
Not in all countries. In Japan, mushroom polysaccharides are leading preparations prescribed alongside chemotherapy. In Europe and the USA they are classified as dietary supplements, but their mechanisms of action are grounded in decades of scientific research.
Lentinan binds to the surface of lymphocytes and activates macrophages, T-cells and NK cells (natural killer cells). It also increases antibody production and helps block the "do not attack me" signals sent by cancer cells.
Three essential criteria: a water-based extract with at least 30% polysaccharides, and a minimum daily dose of 1200 mg. Cheap products with 5-15% polysaccharides are 2-6 times weaker. A formula combining several mushroom extracts with an antioxidant (astaxanthin) is more effective than single ingredients.
Yes. Research shows that mushroom polysaccharides may enhance the effect of chemotherapy, reduce side effects, and improve quality of life. In Japan this is standard practice. Always inform your doctor about the supplements you take.
- DPP-4 inhibitors from fungal sources. Wikipedia
- Alpha-glucosidase inhibitors. Wikipedia
- Mushroom polysaccharides and cancer — review. PMC
- CD47 „don’t eat me“ signal in cancer. Stanford Medicine
- Immune checkpoint therapy. Cancer.gov
- Lentinan modulates PD-L1 expression. Hilaris Publisher
- Antioxidants and chemotherapy: systematic review of 93 clinical trials. PubMed
- Lentinan: antitumor mechanisms and clinical applications. PubMed
- Zhang Y, et al. Efficacy of lentinan with chemotherapy — meta-analysis. PubMed
- Wang J, et al. Lentinan combined with chemotherapy — meta-analysis. PubMed
- Chang Y, et al. Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Prog Mol Biol Transl Sci. 2019. PubMed
- Saleh MH, et al. Immunomodulatory Properties of Coriolus versicolor. Front Immunol. 2017. PubMed
- Wang Y et al. Systematic review and meta-analysis on the efficacy and safety of Injectable Lentinan combined with chemotherapy in the treatment of gastric cancer. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. PubMed
- Oba K et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer research. 2009. PubMed
- Wang Y et al. Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis. Medicine. 2024. PubMed
- Zhang M et al. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Progress in molecular biology and translational science. 2019. PubMed
- Yin X et al. A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer. Indian journal of cancer. 2015. PubMed
- Baral B Holistic Evaluation of Shiitake mushrooms (Lentinula edodes): Unraveling Its Medicinal and Therapeutic Potentials. Chemistry & biodiversity. 2025. PubMed
- Ooi SL et al. Modified Rice Bran Arabinoxylan by Lentinus edodes Mycelial Enzyme as an Immunoceutical for Health and Aging-A Comprehensive Literature Review. Molecules (Basel, Switzerland). 2023. PubMed
- Choi JY et al. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study. Nutrition journal. 2014. PubMed
- Gaullier JM et al. Supplementation with a soluble β-glucan exported from Shiitake medicinal mushroom, Lentinus edodes (Berk.) singer mycelium: a crossover, placebo-controlled study in healthy elderly. International journal of medicinal mushrooms. 2011. PubMed
- Lu H et al. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011. PubMed
- Ooshiro M et al. [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK]. Gan to kagaku ryoho. Cancer & chemotherapy. 2009. PubMed
- Tanaka H et al. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer research. 2012. PubMed
- Maehara Y et al. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer. Cancer chemotherapy and pharmacology. 1993. PubMed
- Ito G et al. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Experimental and therapeutic medicine. 2012. PubMed
- Standish LJ et al. Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society for Integrative Oncology. 2008. PubMed
- Eliza WL et al. Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent patents on inflammation & allergy drug discovery. 2012. PubMed
- He Z et al. Polysaccharide-Peptide from Trametes versicolor: The Potential Medicine for Colorectal Cancer Treatment. Biomedicines. 2022. PubMed
- Chang Y et al. Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Discovery medicine. 2017. PubMed
- Ziaja-Sołtys M et al. Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review. Current issues in molecular biology. 2025. PubMed
- Park JS et al. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutrition & metabolism. 2010. PubMed
- Cheng J et al. The Promising Effects of Astaxanthin on Lung Diseases. Advances in nutrition (Bethesda, Md.). 2021. PubMed
- Lee J et al. Anti-Oxidant and Anti-Inflammatory Effects of Astaxanthin on Gastrointestinal Diseases. International journal of molecular sciences. 2022. PubMed
- Wang T et al. Astaxanthin protected against the adverse effects induced by diesel exhaust particulate matter via improving membrane stability and anti-oxidative property. Journal of hazardous materials. 2023. PubMed
- He J et al. Astaxanthin Alleviates Oxidative Stress in Mouse Preantral Follicles and Enhances Follicular Development Through the AMPK Signaling Pathway. International journal of molecular sciences. 2025. PubMed
- Akramiene D et al. Effects of beta-glucans on the immune system. Medicina (Kaunas, Lithuania). 2007. PubMed
- Ross GD et al. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999. PubMed
- Li B et al. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. Journal of immunology (Baltimore, Md. : 1950). 2006. PubMed
- Liu J et al. Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Experimental and molecular pathology. 2009. PubMed
- Xia Y et al. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. Journal of immunology (Baltimore, Md. : 1950). 1999. PubMed
- Fang J et al. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconjugate journal. 2012. PubMed
- Zhang M et al. β-Glucan from Saccharomyces cerevisiae induces SBD-1 production in ovine ruminal epithelial cells via the Dectin-1-Syk-NF-κB signaling pathway. Cellular signalling. 2019. PubMed
- Gringhuis SI et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nature immunology. 2009. PubMed
- Jia XM et al. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. The Journal of experimental medicine. 2014. PubMed
- Bode K et al. Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2. Cell reports. 2019. PubMed
- Zou X et al. Radioprotective effect of edible and medicinal mushrooms against ionizing radiation: Components, potential mechanisms, and applications. Food research international (Ottawa, Ont.). 2025. PubMed
- Dan A et al. Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review. Cureus. 2023. PubMed
- Abidin MHZ et al. Antiatherogenic Potential of Extracts from the Gray Oyster Medicinal Mushroom, Pleurotus pulmonarius (Agaricomycetes), In Vitro. International journal of medicinal mushrooms. 2018. PubMed
- Zhang X et al. Edible mushroom polysaccharides: Structural characteristics, chemical modification strategies, and structure-activity relationship: A review. International journal of biological macromolecules. 2025. PubMed
- Narayanan S et al. Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies. Current oncology reports. 2023. PubMed
- Wang H et al. Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta-analysis. Cancer medicine. 2017. PubMed
- Oba K et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer immunology, immunotherapy : CII. 2007. PubMed
- Cheng SC et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (New York, N.Y.). 2014. PubMed
- Kidd P Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Alternative medicine review : a journal of clinical therapeutic. 2011. PubMed